Literature DB >> 34823751

Management of Anaphylaxis.

Aishwarya Navalpakam1, Narin Thanaputkaiporn1, Pavadee Poowuttikul2.   

Abstract

The key to managing anaphylaxis is early epinephrine administration. This can improve outcomes and prevent progression to severe and fatal anaphylaxis. Delayed or lack of administration of epinephrine is associated with fatal reactions. Positioning in a recumbent supine position, airway management, and intravenous fluids are essential in its management. Antihistamines and glucocorticosteroids should not be prescribed in place of epinephrine. β-adrenergic agonists by inhalation are indicated for bronchospasm associated with anaphylaxis despite optimal epinephrine treatment. Long-term management of anaphylaxis includes the identification and avoidance of triggers; identification of cofactors, such as mast cell disorders; patient, parent, and caregiver education, and interventions to reduce allergen sensitivity, such as the use of venom immunotherapy for Hymenoptera hypersensitivity. Long-term management is covered in other articles. Consultation with an allergist/immunologist is recommended when necessary.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Anaphylaxis management; Epinephrine; Epinephrine autoinjector; Systemic allergic reaction

Mesh:

Substances:

Year:  2022        PMID: 34823751     DOI: 10.1016/j.iac.2021.09.005

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  2 in total

1.  Safety evaluation of antibacterial and analgesic autoinjector devices for rapid administration during emergency situations: a crossover study in rabbits.

Authors:  Rajagopalan Vijayaraghavan; Sivanesan Senthilkumar; Anitha Roy; Durairajan Sheela; Royapuram Veeraragavan Geetha; Anitha Magesh
Journal:  SAGE Open Med       Date:  2022-07-05

2.  Acute Thrombosis of Left Anterior Descending Coronary Artery During Anaphylactic Reaction to Contrast Dye.

Authors:  John Cox; Cali Clark; Zachary Anderson
Journal:  Cureus       Date:  2022-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.